Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kathleen Schoofs"'
Autor:
Jill Deleu, Kathleen Schoofs, Anneleen Decock, Kimberly Verniers, Sofie Roelandt, Angie Denolf, Joke Verreth, Bram De Wilde, Tom Van Maerken, Katleen De Preter, Jo Vandesompele
Publikováno v:
Human Genomics, Vol 16, Iss 1, Pp 1-14 (2022)
Abstract Background Blood plasma, one of the most studied liquid biopsies, contains various molecules that have biomarker potential for cancer detection, including cell-free DNA (cfDNA) and cell-free RNA (cfRNA). As the vast majority of cell-free nuc
Externí odkaz:
https://doaj.org/article/ef68bffeabae4ba1a11a505e8f590a7c
Autor:
Kathleen Schoofs, Annouck Philippron, Francisco Avila Cobos, Jan Koster, Steve Lefever, Jasper Anckaert, Danny De Looze, Jo Vandesompele, Piet Pattyn, Katleen De Preter
Publikováno v:
Scientific Data, Vol 9, Iss 1, Pp 1-12 (2022)
Measurement(s) mRNA Sequencing • MicroRNA Sequencing Technology Type(s) sequencer Sample Characteristic - Organism Homo sapiens Sample Characteristic - Location Belgium
Externí odkaz:
https://doaj.org/article/d7024e6d48cf4b9f8910695c89064ea4
Autor:
Annelien Morlion, Philippe Decruyenaere, Kathleen Schoofs, Jasper Anckaert, Justine Nuytens, Eveline Vanden Eynde, Kimberly Verniers, Celine Everaert, Fritz Offner, Jo Van Dorpe, Jo Vandesompele, Pieter Mestdagh
Circulating nucleic acids in blood plasma form an attractive resource to study human health and disease. Here, we applied mRNA capture sequencing of blood plasma cell-free RNA from 266 cancer patients and cancer-free controls (discovery n=208, 25 can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b20d8a12ebd043fb92044505b0e2e76
https://doi.org/10.1101/2023.05.24.23290388
https://doi.org/10.1101/2023.05.24.23290388
Autor:
Bert Dhondt, Gary P. Schroth, Celine Everaert, Avila Cobos F, Jasper Anckaert, Nurten Yigit, Jill Deleu, Eva Hulstaert, Van Maerken T, Vanden Eynde E, Piofczyk T, Scott Kuersten, Annelien Morlion, De Wever O, Anneleen Decock, De Wilde J, Kathleen Schoofs, Pieter Mestdagh, Kimberly Verniers, Thibaut D’huyvetter, An Hendrix, Justine Nuytens, Philippron A, Hetty Helsmoortel, Jo Vandesompele, Van Paemel R, Nele Nijs, Carolina Fierro
The use of blood-based extracellular RNA (cell-free RNA; exRNA) as clinical biomarker requires the implementation of a validated procedure for sample collection, processing, and profiling. So far, no study has systematically addressed the pre-analyti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33c22152e1f08a0a56865339c2c14a4c
https://doi.org/10.1101/2021.05.11.442610
https://doi.org/10.1101/2021.05.11.442610
Autor:
Francisco Avila Cobos, Jill Deleu, Ruben Van Paemel, Jasper Anckaert, Justine Nuytens, An Hendrix, Kathleen Schoofs, Nurten Yigit, Olivier De Wever, Eveline Vanden Eynde, Hetty Helsmoortel, Celine Everaert, Eva Hulstaert, Jo Vandesompele, Annelien Morlion, Annouck Philippron, Gary P. Schroth, Scott Kuersten, Bert Dhondt, Anneleen Decock, Pieter Mestdagh, Nele Nijs, Kimberly Verniers, Carolina Fierro
Publikováno v:
Clinical Cancer Research. 26:B49-B49
Cancer biomarker studies require procedures that provide accurate and precise test results with high analytical sensitivity. Consequently, the growing use of extracellular RNA from human biofluids as clinically relevant biomarker requires the impleme